IL124951A - Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same - Google Patents

Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same

Info

Publication number
IL124951A
IL124951A IL12495197A IL12495197A IL124951A IL 124951 A IL124951 A IL 124951A IL 12495197 A IL12495197 A IL 12495197A IL 12495197 A IL12495197 A IL 12495197A IL 124951 A IL124951 A IL 124951A
Authority
IL
Israel
Prior art keywords
microtubules
pct
taxol
depolymerisation
mitosis
Prior art date
Application number
IL12495197A
Other languages
English (en)
Other versions
IL124951A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL124951A0 publication Critical patent/IL124951A0/xx
Publication of IL124951A publication Critical patent/IL124951A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL12495197A 1996-01-31 1997-01-31 Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same IL124951A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19605024A DE19605024A1 (de) 1996-01-31 1996-01-31 Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
PCT/EP1997/000440 WO1997028156A1 (en) 1996-01-31 1997-01-31 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents

Publications (2)

Publication Number Publication Date
IL124951A0 IL124951A0 (en) 1999-01-26
IL124951A true IL124951A (en) 2003-12-10

Family

ID=7785142

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12495197A IL124951A (en) 1996-01-31 1997-01-31 Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same

Country Status (26)

Country Link
US (1) US6162920A (de)
EP (1) EP0896577B1 (de)
JP (1) JP2001505527A (de)
KR (1) KR19990082151A (de)
CN (1) CN1073108C (de)
AT (1) ATE233757T1 (de)
AU (1) AU714313B2 (de)
BR (1) BR9708295A (de)
CA (1) CA2244746A1 (de)
CZ (1) CZ292504B6 (de)
DE (2) DE19605024A1 (de)
DK (1) DK0896577T3 (de)
ES (1) ES2192261T3 (de)
HK (1) HK1018778A1 (de)
HU (1) HUP9901027A3 (de)
IL (1) IL124951A (de)
NO (1) NO983509L (de)
PL (1) PL186796B1 (de)
PT (1) PT896577E (de)
RU (1) RU2163599C2 (de)
SK (1) SK101198A3 (de)
TR (1) TR199801415T2 (de)
TW (1) TW444015B (de)
UA (1) UA49007C2 (de)
WO (1) WO1997028156A1 (de)
ZA (1) ZA97847B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2311591T3 (es) 2001-03-07 2009-02-16 Daiichi Sankyo Company, Limited Proceso para producir un derivado de 2-azetidinona.
EP1605866B1 (de) 2003-03-03 2016-07-06 Syntach AG Implantatvorrichtung für elektrischen leitungsblock
CN1296391C (zh) * 2004-03-04 2007-01-24 中国人民解放军第二军医大学 氟代羧烷基环糊精醚类化合物及其制备方法和应用
US8658203B2 (en) 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
CA2821167C (en) 2004-05-03 2016-06-28 Merrimack Pharmaceuticals, Inc. Drug delivery liposomes containing anionic polyols or anionic sugars
AU2013202947B2 (en) 2012-06-13 2016-06-02 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US9717724B2 (en) 2012-06-13 2017-08-01 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies
US11318131B2 (en) 2015-05-18 2022-05-03 Ipsen Biopharm Ltd. Nanoliposomal irinotecan for use in treating small cell lung cancer
TWI724018B (zh) 2015-08-20 2021-04-11 英商益普生生物製藥有限公司 用於癌症治療之組合療法
EP3337478B1 (de) 2015-08-21 2020-08-12 Ipsen Biopharm Ltd. Arzneimittelkombination enthaltend liposomales irinotecan, oxaliplatin, 5-fluorouracil und leucovorin zur behandlung von metastasierendem pankreaskrebs
SG10201912568PA (en) 2015-10-16 2020-02-27 Ipsen Biopharm Ltd Stabilizing camptothecin pharmaceutical compositions
MX2019004783A (es) 2016-11-02 2019-08-12 Ipsen Biopharm Ltd Tratamiento de cancer gastrico usando terapias de combinacion que comprenden irinotecan liposomico oxaliplatino, 5-fluoruracilo (y leucovorina).

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5489601A (en) * 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
IL109049A (en) * 1993-03-22 2006-12-31 Univ Florida State Texans have a side chain that is converted into pyridyl and pharmaceutical preparations that contain them
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
FR2715307B1 (fr) * 1994-01-25 1996-04-05 Commissariat Energie Atomique Procédé de solubilisation dans un milieu aqueux d'agents antitumoraux de la famille du taxol, et cyclodextrines ramifiées utilisables pour cette solubilisation.
ES2123996T3 (es) * 1994-06-28 1999-01-16 Upjohn Co Analogos de 7-etertaxol, uso antineoplasico y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
DE19605024A1 (de) 1997-08-07
HK1018778A1 (en) 2000-01-07
HUP9901027A2 (hu) 2001-05-28
PL328055A1 (en) 1999-01-04
NO983509D0 (no) 1998-07-30
AU714313B2 (en) 1999-12-23
PL186796B1 (pl) 2004-02-27
HUP9901027A3 (en) 2001-08-28
US6162920A (en) 2000-12-19
ATE233757T1 (de) 2003-03-15
CN1210535A (zh) 1999-03-10
SK101198A3 (en) 1998-12-02
NO983509L (no) 1998-07-30
TW444015B (en) 2001-07-01
ES2192261T3 (es) 2003-10-01
EP0896577A1 (de) 1999-02-17
DE69719502T2 (de) 2004-02-19
RU2163599C2 (ru) 2001-02-27
ZA97847B (en) 1997-08-04
CZ292504B6 (cs) 2003-10-15
DK0896577T3 (da) 2003-05-19
JP2001505527A (ja) 2001-04-24
TR199801415T2 (xx) 1998-10-21
AU1598497A (en) 1997-08-22
DE69719502D1 (de) 2003-04-10
WO1997028156A1 (en) 1997-08-07
KR19990082151A (ko) 1999-11-15
UA49007C2 (uk) 2002-09-16
CA2244746A1 (en) 1997-08-07
EP0896577B1 (de) 2003-03-05
PT896577E (pt) 2003-06-30
CN1073108C (zh) 2001-10-17
IL124951A0 (en) 1999-01-26
CZ242698A3 (cs) 1999-07-14
BR9708295A (pt) 1999-08-03

Similar Documents

Publication Publication Date Title
IL124951A (en) Taxane derivatives having a pyridyl substituted c13 side chain, a process for their preparation and pharmaceutical compositions containing the same
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
ATE145337T1 (de) Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
ES8105283A1 (es) Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
RU94039542A (ru) Производные пиперазина как антагонисты 5-нт-рецепторов, способ получения, фармацевтическая композиция
FI935821A0 (fi) Fosfonooximetylestrar av taxanderivat
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
RU94040859A (ru) Аминопроизводные оксо- и гидрокси-замещенных углеводородов, способы получения, фармацевтические композиции, способ ингибирования ретровирусной протеазы, способ лечения спида у млекопитающих
ES8606370A1 (es) Procedimiento para la obtencion de compuestos de hexapiranosa
ES2168304T3 (es) Derivados del taxol.
FI956341A0 (fi) Metyylifosfonihappoesteri, menetelmä sen valmistamiseksi ja sen käyttö
NO913684L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
RU94036745A (ru) Производные галантамина и фармацевтическая композиция
ATE121949T1 (de) 5,10-methylentetrahydrofolsäure-cyclodextrin- einschlussverbindungen.
AU696532B2 (en) Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
EP0531419A4 (en) Bistriazenes as chemotherapeutic agents
IL108665A (en) Pharmaceutical compositions containing ureido derivatives of substituted pyrroles, certain such novel compounds and their preparation
DZ3046A1 (fr) Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant.
von Angerer New inhibitors of tubulin polymerisation
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
HUP0401405A2 (hu) Xa faktor inhibitor tulajdonságú fenilszármazékok és ezeket tartalmazó gyógyszerkészítmények
GB9621836D0 (en) Peptide compounds
NO913683L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
NO913685D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees